B7-H1 costimulation preferentially enhances CD28-independent T-helper cell function

被引:189
作者
Tamura, H
Dong, HD
Zhu, GF
Sica, GL
Flies, DB
Tamada, K
Chen, LP
机构
[1] Mayo Clin, Dept Immunol, Mayo Grad Sch, Rochester, MN 55905 USA
[2] Mayo Clin, Mayo Med Sch, Dept Immunol, Rochester, MN USA
关键词
D O I
10.1182/blood.V97.6.1809
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
B7-H1 is a recently described B7-like molecule that costimulates T-cell growth and cytokine secretion without binding to CD28, cytotoxic T-lymphocyte antigen-4 (CTLA-4), and inducible costimulator (ICOS), In this report, a mouse homologue of human B7-H1 is identified, and its immunologic functions are studied in vitro and it: vivo, Mouse B7-H1 shares 69% amino acid homology to the human counterpart, Similar to human B7-H1, mouse B7-H1 can be induced to express on macrophages, T cells, and B cells and to enhance T-cell proliferation and secretion of interleukin-10 (IL-10), interferon-gamma, and granulocyte-macrophage colony-stimulating factor but not IL-2 and IL-4, Furthermore, B7-H1 preferentially costimulates CD4(+) T cells independently of CD28 and enhances mixed lymphocyte responses to allogeneic antigens. In contrast to B7-1, expression of B7-H1 on murine P815 tumor cells by transfection fails to increase allogeneic and syngeneic cytolytic T-cell responses in vitro and in vivo. Administration of B7-H1Ig fusion protein, however, enhances keyhole limpet hemocyanin-specific T-cell proliferation and 2,4,6-trinitrophenyl-specific immunoglobulin G2a antibody production. The study thus identifies a unique costimulatory pathway that preferentially affects T-helper cell functions. (Blood, 2001;97:1809-1816) (C) 2001 by The American Society of Hematology.
引用
收藏
页码:1809 / 1816
页数:8
相关论文
共 38 条
[1]   THE YIN AND YANG OF T-CELL COSTIMULATION [J].
ALLISON, JP ;
KRUMMEL, MF .
SCIENCE, 1995, 270 (5238) :932-933
[2]   Class II-transfected tumor cells directly present endogenous antigen to CD4+ T cells in vitro and are APCs for tumor-encoded antigens in vivo [J].
Armstrong, TD ;
Clements, VK ;
Ostrand-Rosenberg, S .
JOURNAL OF IMMUNOTHERAPY, 1998, 21 (03) :218-224
[3]   CD28 COSTIMULATION CAN PROMOTE T-CELL SURVIVAL BY ENHANCING THE EXPRESSION OF BCL-X(L) [J].
BOISE, LH ;
MINN, AJ ;
NOEL, PJ ;
JUNE, CH ;
ACCAVITTI, MA ;
LINDSTEN, T ;
THOMPSON, CB .
IMMUNITY, 1995, 3 (01) :87-98
[4]   HUMAN INTERLEUKIN-10 INDUCES NAIVE SURFACE-IMMUNOGLOBULIN D+ (SIGD(+)) B-CELLS TO SECRETE IGG1 AND IGG3 [J].
BRIERE, F ;
SERVETDELPRAT, C ;
BRIDON, J ;
SAINTREMY, JM ;
BANCHEREAU, J .
JOURNAL OF EXPERIMENTAL MEDICINE, 1994, 179 (02) :757-762
[5]   LICOS, a primordial costimulatory ligand? [J].
Brodie, D ;
Collins, AV ;
Iaboni, A ;
Fennelly, JA ;
Sparks, LM ;
Xu, XN ;
van der Merwe, PA ;
Davis, SJ .
CURRENT BIOLOGY, 2000, 10 (06) :333-336
[6]  
Calderhead DM, 2000, CURR TOP MICROBIOL, V245, P73
[7]  
Cayeux S, 1997, J IMMUNOL, V158, P2834
[8]   Co-stimulation in T cell responses [J].
Chambers, CA ;
Allison, JP .
CURRENT OPINION IN IMMUNOLOGY, 1997, 9 (03) :396-404
[9]   TUMOR IMMUNOGENICITY DETERMINES THE EFFECT OF B7 COSTIMULATION ON T-CELL-MEDIATED TUMOR-IMMUNITY [J].
CHEN, LP ;
MCGOWAN, P ;
ASHE, S ;
JOHNSTON, J ;
LI, YW ;
HELLSTROM, I ;
HELLSTROM, KE .
JOURNAL OF EXPERIMENTAL MEDICINE, 1994, 179 (02) :523-532
[10]   COSTIMULATION OF T-CELLS FOR TUMOR-IMMUNITY [J].
CHEN, LP ;
LINSLEY, PS ;
HELLSTROM, KE .
IMMUNOLOGY TODAY, 1993, 14 (10) :483-486